Imidazole Antimicrobial via One-Pot Ionic Liquid Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a growing need for new antimicrobial agents effective against drug-resistant microorganisms, particularly bacteria and fungi, due to increasing antibiotic resistance, and existing methods for synthesizing organic compounds often require environmentally harmful solvents and inefficient processes.
Innovation Solution
The synthesis of 4,5-bis(4-methoxyphenyl)-1-hexyl-2-phenyl-1H-imidazole via a one-pot four-component reaction using pyridinium hydrogen sulfate as a catalyst and green solvent, demonstrating excellent antimicrobial activity against gram-positive and gram-negative bacteria, as well as fungi.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat bacterial infections, then existing antimicrobial treatments can address common infections, but increasing antibiotic resistance renders them ineffective against drug-resistant microorganisms
Solution Approach 1:
The patent modifies the chemical structure of imidazole compounds by introducing specific substituents (4-methoxyphenyl groups at positions 4 and 5, hexyl group at position 1, and phenyl group at position 2) to change the pharmacological properties and enhance antimicrobial activity against drug-resistant strains
Solution Approach 2:
The compound combines multiple functional groups (imidazole core, methoxyphenyl substituents, alkyl chain, and phenyl group) into a single molecular structure, creating a composite antimicrobial agent with enhanced activity against resistant microorganisms
2Ease of manufacture
If traditional solvents are used for synthesizing organic compounds, then conventional synthesis methods can proceed, but environmentally harmful effects and VOC emissions occur
Solution Approach 1:
The patent converts the traditionally harmful role of solvents into a beneficial one by using ionic liquids as both the reaction medium and catalyst, eliminating the need for separate harmful solvents while enhancing synthesis efficiency and enabling green chemistry protocols
Solution Approach 2:
The ionic liquid serves multiple functions simultaneously: it acts as the reaction solvent, catalyst, and medium for product isolation, eliminating the need for separate solvents and simplifying the synthesis process while being environmentally friendly
3Adaptability or versatility
If multi-step synthesis processes are used to create imidazole derivatives, then complex molecules can be synthesized, but process efficiency decreases and time consumption increases
Solution Approach 1:
The patent merges multiple synthesis steps into a single one-pot reaction where all four components (benzil, aldehyde, ammonium acetate, and amine) react simultaneously in the ionic liquid medium to directly produce the final imidazole derivative, eliminating intermediate isolation steps
Solution Approach 2:
The ionic liquid is prepared in advance and serves as the pre-configured reaction medium that facilitates all subsequent reactions, and the catalyst properties are pre-established through the ionic liquid's composition, enabling efficient one-pot synthesis
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound exhibits high antimicrobial activity against Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Candida albicans, offering a promising therapeutic option with environmentally friendly synthesis methods, potentially addressing antibiotic resistance issues.
Implementation Method 1
pyridinium hydrogen sulfate as a catalyst
Implementation Method 2
demonstrated excellent antimicrobial activities against different microbes. The antibacterial activity of 4,5-bis(4-methoxyphenyl)-1-hexyl-2-phenyl-1H-imidazole was screened against gram-positive bacteria, namely Staphylococcus aureus, and gram-negative bacterial strains, namely Pseudomonas aeruginosa and Escherichia coli, while the antifungal activity was screened against Candida albicans
Data Source
AI summary
A 4,5-bis(4-methoxyphenyl)-1-hexyl-2-phenyl-1H-imidazole compound, its synthesis, and its use as an antimicrobial agent.


